Pricing Log in Create free account

HeartSciences Inc. (HSCS) vs IRIDEX Corporation (IRIX)

HeartSciences Inc. and IRIDEX Corporation are both Medical Devices companies. HeartSciences Inc. is the larger, with a market value of $13.3M against $11.9M — 1.1× the size. HeartSciences Inc. grew revenue faster over the last twelve months: 131.9% against 3.68%. IRIDEX Corporation has the higher net margin (−6.88% vs −48,621.8%) and the lower return on invested capital (−63.1% vs 0.00%). Across the 17 metrics below, IRIDEX Corporation leads on 12 and HeartSciences Inc. on 5.

Valuation

Metric HSCS IRIX Medical Devices median
P/E n/m n/m 24.94
P/S 488.61 0.23 2.66
P/B n/m n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 519.02 0.25 2.76
Earnings yield (114.59%) (29.41%) (12.66%)
Free cash flow yield (69.02%) (16.89%) (7.18%)

Profitability

Metric HSCS IRIX Medical Devices median
Gross margin 18.01% 35.92% 57.76%
Operating margin (44,918.48%) (5.39%) (14.84%)
Net margin (48,621.80%) (6.88%) (14.45%)
Free cash flow margin (33,725.12%) (3.88%) (5.70%)
Return on equity (1,854.69%) 308.17% (10.56%)
Return on assets (201.67%) (12.06%) (17.26%)
Return on invested capital 0.00% (63.07%) (5.22%)

Growth

Metric HSCS IRIX Medical Devices median
Revenue growth (TTM) 131.87% 3.68% 10.41%
EPS growth (last fiscal year) 62.74% 51.85% 28.17%
Revenue growth, 5-year CAGR (30.01%) 7.70% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HSCS IRIX Medical Devices median
Debt to equity 0.00 1.04 0.04
Current ratio 0.14 1.82 2.67
Net debt to EBITDA 0.21 2.68 0.54

Dividend

Metric HSCS IRIX Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric HSCS IRIX Medical Devices median
Market cap 13.26m 11.94m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack